AstraZeneca at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
AstraZeneca takes part in 3 sessions at ACT 2026 in San Antonio. Its program centres on the safety and regulatory roadmap for immune engagers, drugs that steer immune cells toward a target. It also covers how these drugs cause toxicity, traced from lab bench to clinic.
| Organization | ACT 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | ◆Platinum Supporter |
Global pharmaceutical company; its toxicologists chair and speak on safety and regulatory strategy for immune engagers. | Talk Mon Nov 16 2:00pm–2:05pm Session Mon Nov 16 2:00pm–5:00pm Safety and Regulatory Roadmap for Immune Engagers: Strategies to Translate Novel Modalities (S05)
Talk Mon Nov 16 2:05pm–2:30pm |
Instantly find 20 buyers from AstraZeneca
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction